• Revenue down 11% to A$2.8 million
• Loss up 44% to A$10.4 million
• Substantial doubt about company's ability to continue as a going concern

Universal Biosensors, Inc. reported its financial results for the six months ended June 30, 2025. Revenue from ordinary activities declined 11% to A$2.8 million, while loss from ordinary activities after tax attributable to members increased 44% to A$10.4 million. The company's auditor, PricewaterhouseCoopers, noted in its report that substantial doubt exists about Universal Biosensors' ability to continue as a going concern, citing the company's recurring losses since inception and its expectation to continue generating operating losses for the foreseeable future. The interim financial information does not include any adjustments that might result from the outcome of this uncertainty. For the six-month period, the company reported a net tangible assets per ordinary security of A$0.03, down from A$0.09 in the prior year period.